SciSparc Ltd

Contributing Author

Recent Articles by SciSparc Ltd

Oct-24	SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio SPRC GlobeNewswire
Oct-23	SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer SPRC GlobeNewswire
Oct-23	SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery SPRC GlobeNewswire
Oct-20	SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders SPRC GlobeNewswire
Oct-15	SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio SPRC GlobeNewswire
Oct-06	SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors SPRC GlobeNewswire
Sep-29	SciSparc: N2OFF Shareholders Approve Merger with SciSparc's Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer SPRC GlobeNewswire
Sep-25	SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery SPRC GlobeNewswire
Aug-28	SciSparc: AutoMax's Shareholders Approve Merger with SciSparc SPRC GlobeNewswire
Aug-28	SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel SPRC GlobeNewswire
Aug-07	SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar SPRC GlobeNewswire
Jul-30	SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC SPRC GlobeNewswire
Jul-30	SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease SPRC GlobeNewswire
Jul-22	SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification SPRC GlobeNewswire
Jun-24	SciSparc Announces 1-for-21 Reverse Share Split SPRC GlobeNewswire
May-27	SciSparc Announces Publication of Japanese Patent Application SPRC GlobeNewswire
May-12	SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction SPRC GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.